Anakinra-Induced Acute Liver Failure in an Adolescent Patient with Still's Disease
- 9 January 2016
- journal article
- case report
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 36 (1), e1-e4
- https://doi.org/10.1002/phar.1677
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Subacute Liver Failure Following Anakinra Treatment for Adult-onset Still DiseaseThe Journal of Rheumatology, 2013
- Hépatite aiguë médicamenteuse à l’anakinra chez une patiente traitée pour une maladie de Still de l’adulteLa Revue de Médecine Interne, 2013
- Comparison of Three Pharmacovigilance Algorithms in the ICU SettingDrug Safety, 2012
- Amniotic-Fluid–Derived Mesenchymal Stem Cells Overexpressing Interleukin-1 Receptor Antagonist Improve Fulminant Hepatic FailurePLOS ONE, 2012
- Anakinra as an interleukin 1 receptor antagonist, complicated genetics and molecular impacts- from the point of view of mouse genomicsInternational Immunopharmacology, 2012
- Interleukin-1 Receptor Antagonist Modulates the Early Phase of Liver Regeneration after Partial Hepatectomy in MicePLOS ONE, 2011
- Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reportsInternational Journal of General Medicine, 2011
- Acute hepatitis in three patients with systemic juvenile idiopathic arthritis taking interleukin-1 receptor antagonistPediatric Rheumatology, 2009
- Acute hepatitis in adult Still’s disease during corticosteroid treatment successfully treated with anakinraClinical Rheumatology, 2007
- Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United StatesAnnals of Internal Medicine, 2002